Nebcin and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nebcin (tobramycin sulfate) and Ceftazidime (ceftazidime). Common drug interactions include insomnia among females and maternal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Nebcin and Ceftazidime. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Nebcin?

Nebcin has active ingredients of tobramycin sulfate. eHealthMe is studying from 217 Nebcin users. Check the latest studies of Nebcin.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

14 people who take Nebcin and Ceftazidime together, and have interactions are studied.

Nebcin and Ceftazidime drug interactions.

What are the common drug interactions of Nebcin and Ceftazidime, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Leukocytosis (increased white blood cells)
  3. Nausea (feeling of having an urge to vomit)
  4. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  5. Vitamin d decreased
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Acute sinusitis
  8. Chest discomfort
  9. Drug hypersensitivity
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

What are the common drug interactions of Nebcin and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)

2-9:

n/a

10-19:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

20-29:

n/a

30-39:

  1. Abdominal pain upper
  2. Anxiety
  3. Asthma
  4. Constipation
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Haemoglobin decreased
  7. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  8. Insomnia (sleeplessness)
  9. Leukocytosis (increased white blood cells)
  10. Nausea (feeling of having an urge to vomit)

40-49:

  1. Post procedural complication
  2. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  7. Sputum purulent
  8. Weight increased
  9. Diaphragmatic paralysis (acquired dysfunction of the phrenic nerve)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

50-59:

n/a

60+:

  1. Diarrhoea
  2. Erythema (redness of the skin)
  3. Pruritus (severe itching of the skin)
  4. Purpura (purplish discoloration of the skin)
  5. Skin lesion
  6. Tinnitus (a ringing in the ears)

What are the existing conditions these people have? *

  1. Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 3 people, 21.43%
  2. The Flu (the flu is caused by an influenza virus): 3 people, 21.43%
  3. Asthma: 3 people, 21.43%
  4. Birth Control: 3 people, 21.43%
  5. Chest Pain: 3 people, 21.43%
  6. Constipation: 3 people, 21.43%
  7. Cystic Fibrosis (disease of the secretary glands): 3 people, 21.43%
  8. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 3 people, 21.43%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 21.43%
  10. Depression: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Nebcin and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nebcin and Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nebcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nebcin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tobramycin sulfate and ceftazidime (the active ingredients of Nebcin and Ceftazidime, respectively), and Nebcin and Ceftazidime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: